Sunday, July 4, 2021

Report urges pharma companies to utilise synthetic data in clinical trials

A new report from Phesi and Accenture is encouraging pharmaceutical companies to utilise synthetic data in clinical trials.

Synthetic data is based on real-world data sets, used to accurately predict the ‘synthetic patient profile’ and deploy a virtual cohort in a clinical trial.

The report is the first in a series exploring the use of synthetic data in clinical development. It outlines two cases where synthetic data was used within the clinical trial process – in oncology and gastroenterology.

In oncology, trials can be costly and time-intensive – in a study without a synthetic control arm, the median R&D cost for oncology drugs is $2.77bn.

In addition, recruiting patients can also be a challenge in oncology, meaning it often takes longer to get treatments to market.

The report details how synthetic data could help to overcome some of these challenges, by reducing patient numbers and eliminating placebos to accelerate the process.

In addition, the report found that in ulcerative colitis, synthetic patient data could be used to synthesise baseline patient characteristics to ‘optimise’ protocol design.

This could also reduce patient numbers and exposure to a comparator, according to the report authors.

“It is important to limit the burden on patients participating in a clinical trial. Many avoid clinical trials altogether as worries over receiving a placebo treatment dissuade them,” said Boris Bogdan, managing director, Accenture.

“Synthetic patient data minimises the need for placebos and accelerates the development process,” he added.

Source link

Stay Connected


Latest Articles

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...

Telangana caps Covid treatment charges in private hospitals

Hyderabad: The government of Telangana on Wednesday issued orders fixing treatment and investigation charges for Covid-19 in private hospitals.The state government, which had capped...